NCT05270954 Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2 Status UNKNOWN Phase PHASE1/PHASE2
NCT05270694 Evaluating Public Health Interventions to Improve COVID-19 Testing Among Underserved Populations Status COMPLETED Phase NA
NCT05268939 Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment Status COMPLETED Phase N/A
NCT05268601 COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 Status COMPLETED Phase N/A
NCT05268380 Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia Status COMPLETED Phase N/A
NCT05268198 SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects Status COMPLETED Phase EARLY_PHASE1
NCT05268185 The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19) Status COMPLETED Phase NA
NCT05265065 Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia. Status COMPLETED Phase PHASE3
NCT05264987 Outcomes of Obstetric Patients With COVID-19 Disease in the ICU Status COMPLETED Phase N/A
NCT05261139 EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease Status RECRUITING Phase PHASE3
NCT05261061 Prognosis of Geriatric Patients 1 Year After Hospitalization for COVID-19 Status UNKNOWN Phase N/A
NCT05260437 Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants Status COMPLETED Phase PHASE1
NCT05258734 The Effect of Mobile Health Application Based on Omaha System on Symptoms and Quality of Life in COVID-19 Patients Status COMPLETED Phase NA
NCT05258682 Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease Status UNKNOWN Phase PHASE1/PHASE2